Amedica

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Amedica and buy or sell other stocks, ETFs, and their options commission-free!

About AMDA

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. 

CEO
Eric Kenneth Olson
CEOEric Kenneth Olson
Employees
Employees
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1996
Founded1996
Employees
Employees

AMDA Key Statistics

Market cap
9.69M
Market cap9.69M
Price-Earnings ratio
-0.38
Price-Earnings ratio-0.38
Dividend yield
Dividend yield
Average volume
59.17K
Average volume59.17K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.78
52 Week high$6.78
52 Week low
$1.99
52 Week low$1.99

Stock Snapshot

The current Amedica(AMDA) stock price is $0.94, with a market capitalization of 9.69M. The stock trades at a price-to-earnings (P/E) ratio of -0.38.

Amedica(AMDA) stock opened on 2026-05-09 at —. The price climbed to — and dipped to —.

Amedica(AMDA) shares are trading with a volume of 0, against a daily average of 59.17K.

In the last year, Amedica(AMDA) shares hit a 52-week high of $6.78 and a 52-week low of $1.99.

In the last year, Amedica(AMDA) shares hit a 52-week high of $6.78 and a 52-week low of $1.99.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.